Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Recurrent immature teratoma in a 47 year old with maturation in subsequent laparotomies and a grave course
1Sarita Kumari, All India Institute of Medical Sciences, New Delhi, pin-110029, India
2Jai Bhagwan Sharma, Dept of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, pin-110029, India
DOI: 10.31083/j.ejgo.2020.05.5330 Vol.41,Issue 5,October 2020 pp.813-816
Submitted: 01 August 2019 Accepted: 14 January 2020
Published: 15 October 2020
*Corresponding Author(s): Sarita Kumari E-mail: sarita2325@gmail.com
Ovarian immature teratoma (IT) is uncommon after the first two decades of life. Management is largely surgical, and recurrences are rare. Ovarian IT has the potential to convert into mature disease at the time of recurrence. The current case report describes a 47-year-old female patient who developed two recurrences within three years. The primary disease and first recurrence were managed surgically, whereas the second recurrence was managed surgically plus adjuvant chemotherapy with bleomycin, etoposide and cisplatin (BEP) regimen. Histopathology was immature teratoma grade 3 initially which progressed to immature teratoma grade 1 in last recurrence. Alphafeto protein levels were never raised except two months after the last laparotomy when the patient was diagnosed to have hepatic metastases and succumbed to disease. Prognosis was grave in our patient. Advanced age may be a one contributing factor. Relapse of ovarian IT is uncommon and its optimal management remains debatable.
Recurrent immature teratoma; Ovarian; Surgery.
Sarita Kumari,Jai Bhagwan Sharma. Recurrent immature teratoma in a 47 year old with maturation in subsequent laparotomies and a grave course. European Journal of Gynaecological Oncology. 2020. 41(5);813-816.
[1] Quirk J.T., Natarajan N.: “Ovarian cancer incidence in the United States, 1992-1999”. Gynecol. Oncol., 2005, 97, 519.
[2] Luczak J., Baglaj M.: “Ovarian teratoma in children: a plea for col-laborative clinical study”. J. Ovarian. Res., 2018, 11, 75.
[3] Barbosa L.C., Francisco A.M., Archangelo Sde.C., Soares F.C., Ferreira M.C., Maia R.L.: “Bilateral immature ovarian teratoma in a12-year old girl: case report”. Rev. Assoc. Med. Bras., 2012, 58, 138.
[4] Billmire D., Vinocur C., Rescorla F., Cushing B., London W., Schlatter M., et al.: “Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study”. J. Pediatr. Surg., 2004, 39, 424.
[5] Gershenson D.M.: “Management of ovarian germ cell tumors”. J. Clin. Oncol., 2007, 25, 2938.
[6] Jeffery G.M., Theaker J.M., Lee A.H.S., Blaquiere R.M., Smart C.J., Mead G.M., et al.: “The growing teratoma syndrome”. Br. J. Urol., 1991, 67, 195.
[7] Mrabti H., El Ghissassi J., Sbitti Y., Amrani M., Hachi H., Errihani H.: “Growing teratoma syndrome and peritoneal gliomatosis”. Case Rep. Med., 2011, 2011, 123527.
[8] Shibata K., Kajiyama H., Kikkawa F.: “Growing teratoma syndrome of the ovary showing three patterns of metastasis: a case report”. Case Rep. Oncol., 2013, 6, 544.
[9] Kampan N., Irianta T., Djuana A., Shan L.P., Omar H., Dali A.: “Growing teratoma syndrome: a rare case report and review of the literature”. Case Rep. Obstet. Gynecol., 2012, 2012, 134032.
[10] Logothetis C.J., Samuels M.L., Trindade A., Johnson D.E.: “The growing teratoma syndrome”. Cancer., 1982, 50, 1629.
[11] Li X., Zhu D., Lv L.I., Yu J.: “ An uncommon recurrence of an immature teratoma: a case report”. Oncol. Lett., 2016, 11, 2453.
[12] Pashankar F., Hale J.P., Dang H., Krailo M., Brady W.E., Rodriguez-Galindo C., et al.: “Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative”. Cancer., 2016, 122, 230.
[13] Cushing B., Giller R., Ablin A., Cohen L., Cullen J., Hawkins E., et al.: “Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children’s cancer group”. Am. J. Obstet.Gynecol., 1999, 181, 353.
[14] Newton C., Murali K., Ahmad A., Hockings H., Graham R., Lib-erale V., et al.: “A multicentre retrospective cohort study of ovarian germ cell tumours: evidence for chemotherapy de-escalation and alignment of paediatric and adult practice”. Eur. J. Cancer., 2019, 113, 19.
[15] O’Connor D.M., Norris H.J.: “The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading”. Int. J. Gynecol. Pathol., 1994, 13, 283.
[16] Pectasides D., Pectasides E., Kassanos D.: “Germ cell tumors of the ovary”. Cancer. Treat. Rev., 2008, 34, 427.
[17] Mann J.R., Gray E.S., Thornton C., Raafat F., Robinson K., Collins G. S., et al.: “Mature and immature extracranial teratomas in children: the UK Children’s Cancer Study Group Experience”. J. Clin. Oncol., 2008, 26, 3590.
[18] Zagame L., Pautier P., Duvillard P., Castaigne D., Patte C., LhommeC.: “Growing teratoma syndrome after ovarian germ cell tumors”. Obstet. Gynecol., 2006, 108, 509.
[19] Gorbatiy V., Spiess P.E., Pisters L.L.: “The growing teratoma syndrome: current review of the literature”. Indian. J. Urol., 2009, 25, 186.
[20] Li S., Liu Z., Dong C., Long F., Liu Q., Sun D., et al.: “Growing teratoma syndrome secondary to ovarian giant immature teratoma in an adolescent girl”. Medicine (Baltimore)., 2016, 18, 95.
Top